NCT06270082
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06270082
Title Study of IK-595 in RAS- or RAF-altered Advanced Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Ikena Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California Irvine Orange California 92868 United States Details
Sarah Cannon Research Institute at HealthOne Denver Colorado 80218 United States Details
Johns Hopkins University of Medicine Sidney Kimmel Comprehensive Care Center Washington D.C. District of Columbia 20016 United States Details
University of Miami Miami Florida 33136 United States Details
University of Chicago Chicago Illinois 60637 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Medical Center- Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Next Oncology Austin Texas 78758 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Next Oncology- San Antonio San Antonio Texas 78229 United States Details
INOVA Schar Cancer Institute Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field